Lipin 1 plays a role in abdominal obesity, insulin resistance, and hypertriglyceridemia. The gene is located at 2p25.1, a susceptibility locus for hypertension. We studied the association of tagging single-nucleotide polymorphisms (SNPs) in the lipin 1 (LPIN1) gene with hypertension and blood pressure.
Hypertension is a common disease with a complex etiology. Genome-wide scans for hypertension have yielded inconsistent or even negative results, making the identification of genetic variants for hypertension a daunting challenge. [1] [2] [3] A recent high-resolution mapping for essential hypertension, using microsatellite markers, has revealed a significant association between the microsatellite D2S0949i at chromosome 2p25.1 and hypertension in a Japanese population with an odds ratio of 1.54 (95% confidential interval: 1.08-2.21). 3 A previous study also demonstrated suggestive evidence linking hypertension with microsatellite markers at the same chromosomal locus, 2p25.1, in African Americans. 4 The microsatellite marker D2S0949i is located within the gene LPIN1, encoding lipin 1. 3 Lipin 1 is expressed in adipose tissue and plays a role in adipogenesis. 5 In mice, mutation in LPIN1 causes lipin 1 deficiency and lipodystrophy, which is characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. 6 Genetic polymorphisms in LPIN1 are associated with serum insulin level and body mass index (BMI). 7 Because lipin 1 is associated with obesity, insulin resistance, and hypertriglyceridemia, all of which are components of the metabolic syndrome, lipin 1 may play a role in hypertension or blood pressure regulation. Therefore, in this study, we investigated the associations of tagging single-nucleotide polymorphisms (SNPs) in LPIN1 with blood pressure and hypertension in a case-control study in Hong Kong Chinese subjects.
Methods
Subjects. The study included 675 unrelated Hong Kong Chinese subjects from a cohort of adults originally randomly recruited from the general population in Hong Kong. 8 The sample consisted of 268 hypertensive subjects and 407 normotensive controls, of whom 268 matched the cases in age and sex. The 268 hypertensive subjects and 139 unmatched normotensive subjects were randomly selected from the cohort. Hypertension was defined as blood pressure ≥140/90 mm Hg or the use of antihypertensive medications. The study protocol was approved by the Faculty Ethics Committee, and written informed consent was obtained from all participants before blood samples were taken.
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The clinical characteristics, including lipid profile, fasting glucose, insulin, and homeostasis model assessment of insulin resistance index (HOMA-IR), were measured in each subject as described earlier. 8 A physical examination was performed and a full medical history was obtained using a standard questionnaire. Blood pressure was measured using a mercury sphygmomanometer by a trained nurse as described earlier. 8 Genotyping. Blood samples were taken and genomic DNA was extracted from the buffy coat using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). Tagging SNPs with r 2 ≥ 0.85 and minor allele frequency ≥0.10 were selected from the database on Han Chinese in HapMap. There were 13 tagging SNPs that captured all the 40 known SNPs in the LPIN1 gene in HapMap (Phase II data, release 22), from 3 kb upstream to 1 kb downstream of the gene (position 11801191-11885986, GenBank accession number NC_000002) (Figure 1) . One tagging SNP, rs11524, could not be incorporated into the multiplex assay design, and therefore 12 tagging SNPs were chosen for genotyping. This does not constitute a problem because rs11524 and rs10495584 (which was genotyped) are in high linkage disequilibrium (LD) (r 2 = 0.837) in Han Chinese, according to HapMap. Genotyping was performed using the Sequenom MassArray platform (Sequenom, San Diego, CA). The iPLEX assay was performed in accordance with the manufacturer's instructions. 9 In all the analyses, subjects who were homozygous for the minor allele were grouped along with heterozygotes and compared with those who were homozygous for the major allele, so as to increase the overall sample size for comparison. The false discovery rate was set at 0.05 to correct for multiple testing. 10 Multiple regression was used for assessing the independent association of SNPs with dependent variables after adjusting for confounding factors. Haplotype analysis was performed using the program PLINK in a sliding window mode with two, three, four, and five consecutive markers across all the 11 SNPs. 11 Variables with skewed distribution were log-transformed in the regression models. A two-tailed P value <0.05 was considered statistically significant.
Statistically similar SNPs
Using Genetic Power Calculator 12 and assuming a disease prevalence of 25%, our study of 268 hypertensive subjects and 268 controls had 80% power to detect an odds ratio of 1.86 for allele frequency of 0.10 at the 5% significance level under a dominant inheritance model.
results
Baseline characteristics of study subjects
The baseline characteristics of the subjects are shown in Table 1 . Hypertensive subjects had significantly higher mean blood pressures, BMI, waist circumference, plasma triglycerides, fasting insulin, and HOMA-IR, but lower mean highdensity lipoprotein (HDL) cholesterol and current smoking percentage, in comparison with the age-and sex-matched normotensive control subjects. Among these hypertensive subjects, 146 (54.5%) were receiving anti-hypertensive drug treatment. When compared with the age-and sex-matched controls, the other 139 normotensive controls were younger and had significantly lower blood pressure, fasting glucose, prevalence of diabetes, and former smoking percentage, and a lower proportion of men.
genotyping and ld pattern
The genotyping completion rate was ≥97.8% in all the SNPs except SNP rs16857876, which was genotyped in 80.4% of the subjects. This SNP showed significant deviation from Hardy-Weinberg equilibrium (P < 0.001) and was therefore not analyzed. The remaining 11 SNPs captured 38 (95%) out of 40 SNPs with r 2 ≥ 0.85 and minor allele frequency ≥0.10 genotyped in the HapMap Han Chinese population. The average r 2 value across all SNP pairs in LPIN1 gene was 0.27. Moderate-to-high LD was found in three SNP pairs, rs4669778 and rs7595221 (r 2 = 0.70), rs7595221 and rs2278513 (r 2 = 0.89), and rs11695081 and rs10520097 (r 2 = 0.91) (Figure 2) . The pairwise LD pattern in our sample was similar to that in the HapMap Han Chinese population, except that three SNP pairs, rs10520097 and rs10495584, rs11695081 and rs10520097, and rs11695081 and rs11695610 showed significant differences in LD between our sample and the HapMap Han Chinese association with hypertension Table 2 shows the genotype distribution in three groups of subjects. There were no significant differences in genotype frequency between matched controls and the remaining controls for any of the 11 SNPs (P > 0.05). In case-control analysis of 268 hypertensive subjects and 268 matched controls, carriers of the minor allele of rs10520097 (odds ratio = 0.590; P = 0.014) had nominally lower odds for hypertension. However, this was no longer significant after correcting for multiple testing of 11 SNPs.
association with blood pressure
In order to examine the association of genotype with blood pressure as a continuous trait, we included all the normotensive subjects and excluded 146 hypertensive subjects who were on anti-hypertensive drug treatment. Overall, carriers of the minor alleles of rs11695610 and rs10495584 had nominally lower mean systolic blood pressure than the non-carriers (120.3 ± 13.2 mm Hg vs. 124.1 ± 18.3 mm Hg, P = 0.033 and 120.8 ± 15.5 mm Hg vs. 124.4 ± 18.4 mm Hg, P = 0.025, respectively) ( Table 3) . However, such associations were no longer significant after correcting for multiple testing of 11 SNPs for the two blood pressure phenotypes.
In sex-specific analysis (Table 3) , the minor allele carriers of rs10495584 were nominally associated with lower mean systolic and diastolic blood pressures than non-carriers in men (n = 78, 121.1 ± 14.2 and 76.3 ± 10.2 mm Hg vs. n = 199, 127.4 ± 15.2 and 80.1 ± 10.5 mm Hg, P = 0.002 and 0.007, respectively), but not in women (P > 0.05). The association of rs10495584 with systolic (but not diastolic) blood pressure in men remained significant after correcting for multiple testing of 11 SNPs for the two blood pressure phenotypes. In men, carriers of the minor allele of rs10495584 had significantly lower BMI (23.1 ± 3.5 kg/m 2 vs. 24.5 ± 3.3 kg/m 2 , P = 0.001), lower waist circumference (81.6 ± 9.8 vs. 84.7 ± 9.0 cm, P = 0.001), and lower plasma triglyceride (1.1 (0.8-1.6) vs. 1.3 (0.9-1.9) mmol/l, P = 0.026) than non-carriers, but there were no significant differences in any of the other baseline characteristics, as shown in Table 1 . The association of rs10495584 with systolic blood pressure as determined using multiple linear regression remained significant (β = −0.159, P = 0.005) after adjusting for age, waist circumference, HOMA-IR (logtransformed), triglyceride (log-transformed), HDL cholesterol, current smoking, and former smoking. Replacement of waist circumference with BMI in the regression analysis did not result in any significant change (β = −0.153, P = 0.007). Multiple regression analysis, in which rs10495584 and all the articles
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variables shown in Table 1 (except blood pressure) were entered stepwise, showed that rs10495584 (β = −0.149, P = 0.009), age (β = 0.292, P < 0.001), BMI (β = 0.158, P = 0.012), HDL cholesterol (β = 0.139, P = 0.047), triglyceride (log-transformed, β = 0.212, P = 0.001), and former smoking (β = 0.142, P = 0.013) were the significant independent predictors of systolic blood pressure (r 2 = 0.191). Haplotype analysis revealed a more significant association of the haplotype GC (comprising SNPs rs10495584 and rs1050800 and present in 14.4% of the subjects) with lower systolic blood pressure in men (regression coefficient = −6.716, P = 0.0004).
sssnPs and prediction of functional effects
The SNP rs10495584 has four ssSNPs, rs1370547, rs2716610, rs2716609, and rs11524, all located in the LPIN1 gene ( Table 4) .
The results of an analysis of these SNPs using the PupaSuite program suggested that the major allele of rs11524 (T) may form an exonic splicing silencer sequence (TGTTAG), and all of them, articles Genetic Polymorphisms in Lipin 1 except rs2716610 and rs1370547, are located in conserved regions common to humans and mice. discussion This is the first report of the association of genetic polymorphisms in the LPIN1 gene with systolic blood pressure in men.
The present results confirm and extend the results of a recent genome scan in Japan that suggested LPIN1 as a candidate gene for hypertension. 3 The association of rs10495584 with hypertension did not reach statistical significance, which could be because of insufficient power in the study design, the involvement of multiple genes in the etiology of hypertension, and misclassification of hypertension status. Moreover, blood pressure is a continuous variable whereas hypertension is a discrete variable. Thus, an SNP associated with a 6.3 mm Hg change in systolic blood pressure may be insufficient to cause hypertension in someone whose blood pressure is in the normal range. Certainly, the use of tagging SNPs did not result in any loss of power. 13 An analysis of ssSNPs in the surrounding regions suggested that the causative variants for systolic blood pressure are located in LPIN1. SNPs in LPIN1 are associated not only with blood pressure but also with serum insulin level and BMI, 7 and therefore functional studies are needed for unraveling the direct functional consequences of genetic variants in LPIN1. Lipin 1 is the phosphatidic acid phosphatase that produces diacylglycerol in adipocytes. 14 It has two isoforms (α and β) produced by alternative mRNA splicing. 15 Lipin 1α is predominantly localized to the nucleus, stimulates expression of genes involved in adipocyte differentiation, and thereby enhances the expression of PPAR-γ and adipocyte fatty acid-binding protein (aP2). 15 aP2 is an abundant protein in the cytosol of mature adipocytes. Its serum level correlates with carotid atherosclerosis and predicts the development of the metabolic syndrome and type 2 diabetes in long-term prospective studies in our population. [16] [17] [18] Lipin 1β is predominantly localized to the cytoplasm, stimulates the expression of genes involved in lipogenesis and 19, 20 Insulin stimulates the phosphorylation of lipin 1 through the mammalian target of the rapamycin pathway. 21 In contrast, epinephrine and oleic acid promote dephosphorylation of lipin 1. 22 These substances modulate the phosphatidic acid phosphatase activity of lipin 1 by changing its subcellular localization.
Chromosome 2p25 has also been linked to plasma levels of N-terminal proatrial natriuretic peptide. 23 Natriuretic peptides play a role in sodium homeostasis and blood pressure regulation. 24, 25 Obese individuals in Framingham were found to have low circulating levels of natriuretic peptides. 26 The interaction between LPIN1 and the natriuretic peptides warrants further investigation.
Like adiponectin, the expression of lipin 1 in subcutaneous adipose tissue is lower in subjects with obesity and the metabolic syndrome. 20 We have previously shown, in the Hong Kong Chinese population, that obesity and the metabolic syndrome precede and predict the development of hypertension. 27 Obesity can lead to hypertension through the activation of the renin-angiotensin and sympathetic nervous systems, sodium and water retention, expansion in extracellular fluid volume and increase in glomerular filtration rate. 28 A recent study in Caucasians revealed a significant association between genetic variants in LPIN1 and human metabolic traits, including blood pressure, BMI, waist circumference, and glycosylated hemoglobin level. 29 In our study, the association of rs10495584 with blood pressure in men, but not in women, is not surprising, and is consistent with other reports. For instance, the SNP rs11693809 in LPIN1 was associated with serum insulin level in men only, 7 although we did not study this SNP because it has not been chosen for inclusion in the HapMap database. We found that men who were carriers of the minor allele of rs10495584 had significantly lower BMI, lower waist circumference, and lower plasma triglyceride than noncarriers. It is possible that lipin 1 plays a more important role in obesity in men than in women. Men and pre-menopausal women have different patterns of fat accumulation. Men are more prone to central obesity that is more associated with the metabolic syndrome and cardiovascular risk. Interestingly, physical activity, which reduces intra-abdominal adiposity effectively, increases the expression of LPIN1. 30 In conclusion, our study demonstrated a significant association between rs10495584 and systolic blood pressure in men. Although this SNP is in high LD with rs11524, in which the major allele forms an exonic splicing silencer sequence, it remains to be established how these two SNPs affect blood pressure by alternative splicing. 
